Belviq (generic name: lorcaserin) is a popular prescription weight-loss drug made by Eisai Inc. to help people experiencing obesity and weight-related health issues curb their hunger. Alarmingly, a U.S. Food and Drug Administration (FDA) safety trial concluded that the drug could increase the risk of several different types of cancer, including pancreatic, lung, and colorectal cancer. As a result, the FDA issued a full recall of Belviq in February 2020.
If you or a loved one took Belviq, Belviq XR, or another brand of lorcaserin, and you were diagnosed with cancer, you may be entitled to compensation from the drug’s manufacturer. Fill out a free case review form to find out if you are owed money for damages.